Inhibrx (NASDAQ:INBX – Get Free Report) and Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and profitability. Risk and Volatility Inhibrx has a beta […]
Citigroup Inc. lifted its position in Inhibrx, Inc. (NASDAQ:INBX – Free Report) by 43.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,335 shares of the company’s stock after acquiring an additional 37,822 shares during the quarter. Citigroup […]
Inhibrx (NASDAQ:INBX – Get Free Report) and Zura Bio (NASDAQ:ZURA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Earnings and Valuation This table compares Inhibrx and […]
Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) shares traded down 4.2% during mid-day trading on Wednesday . The stock traded as low as $20.73 and last traded at $21.00. 311,518 shares were traded during mid-day trading, a decline of 21% from the average session volume of 392,497 shares. The stock had previously closed at $21.93. […]
JMP Securities Cuts Inhibrx (NASDAQ:INBX) Price Target to $27 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.